PharmAthene Inc. is a biodefense company which is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.


Updates from The Motley Fool

Latest updates on PharmAthene from Fool.com.


Stock Performance

PIP vs. S&P 500 | 2 Year Performance
View Interactive PIP Charts
Sponsored by

Key Data Points

Primary metrics and data points about PharmAthene.
Current Price: $2.57
Prev Close: $2.56
Open: $2.54
Bid: $2.56
Ask: $2.57
Day's Range: $2.54 - $2.57
52wk Range: $1.20 - $2.60
Volume: 19,015
Avg Vol 421,991
Market Cap: $165.64M
P/E (ttm): -12.19
EPS (ttm): -$0.21
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about PharmAthene.
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think PharmAthene will perform against the market?



You pick for PharmAthene is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Eric I. Richman, CEO

74% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PharmAthene.

PharmAthene Inc. is a biodefense company which is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers